comparemela.com
Home
Live Updates
Data Expected This Summer - Breaking News
Pages:
Latest Breaking News On - Data expected this summer - Page 1 : comparemela.com
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
– Dordaviprone (ONC201) ACTION Study Progressing; Reiterates Expectations for Interim Overall Survival (OS) Data in 2025 and Final OS Data in 2026.
Mike andriole
Marcd kozin
Patrick machado
Oncology consortium
Therapeutic goods administration
National institutes of health
Company to advance dordaviprone
Exchange commission
Company board of directors
Reiterates expectations
Interim overall survival
Preliminary phase
Data expected this summer
Advance dordaviprone
Conference call
Chief executive officer
vimarsana © 2020. All Rights Reserved.